{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:30:12Z","timestamp":1789050612723,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR300826"],"award-info":[{"award-number":["NIHR300826"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Applied Research Collaboration West Midlands"},{"DOI":"10.13039\/501100013374","name":"NIHR School for Primary Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Despite little evidence that analgesics are effective in inflammatory arthritis (IA), studies report substantial opioid prescribing. The extent this applies to other analgesics is uncertain. We undertook a comprehensive evaluation of analgesic prescribing in patients with IA in the Clinical Practice Research Datalink Aurum to evaluate this.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>From 2004 to 2020, cross-sectional analyses evaluated analgesic prescription annual prevalence in RA, PsA and axial spondyloarthritis (axSpA), stratified by age, sex, ethnicity, deprivation and geography. Joinpoint regression evaluated temporal prescribing trends. Cohort studies determined prognostic factors at diagnosis for chronic analgesic prescriptions using Cox proportional hazards models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Analgesic prescribing declined over time but remained common: 2004 and 2020 IA prescription prevalence was 84.2\/100 person-years (PY) (95% CI 83.9, 84.5) and 64.5\/100\u2009PY (64.2, 64.8), respectively. In 2004, NSAIDs were most prescribed (56.1\/100\u2009PY; 55.8, 56.5), falling over time. Opioids were most prescribed in 2020 (39.0\/100\u2009PY; 38.7, 39.2). Gabapentinoid prescribing increased: 2004 prevalence 1.1\/100\u2009PY (1.0, 1.2); 2020 prevalence 9.9\/100\u2009PY (9.7, 10.0). Most opioid prescriptions were chronic (2020 prevalence 23.4\/100\u2009PY [23.2, 23.6]). Non-NSAID analgesic prescribing was commoner in RA, older people, females and deprived areas\/northern England. Conversely, NSAID prescribing was commoner in axSpA\/males, varying little by deprivation\/geography. Peri-diagnosis was high-risk for starting chronic opioid\/NSAID prescriptions. Prognostic factors for chronic opioid\/gabapentinoid and NSAID prescriptions differed, with NSAIDs having no consistently significant association with deprivation (unlike opioids\/gabapentinoids).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>IA analgesic prescribing of all classes is widespread. This is neither evidence-based nor in line with guidelines. Peri-diagnosis is an opportune moment to reduce chronic analgesic prescribing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead463","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:22:57Z","timestamp":1697088177000},"page":"1672-1681","source":"Crossref","is-referenced-by-count":14,"title":["Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-9808","authenticated-orcid":false,"given":"Ian C","family":"Scott","sequence":"first","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"},{"name":"Haywood Academic Rheumatology Centre, Haywood Hospital, Midlands Partnership NHS Foundation Trust, High Lane , Burslem, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Whittle","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bailey","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Twohig","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-3909","authenticated-orcid":false,"given":"Samantha L","family":"Hider","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"},{"name":"Haywood Academic Rheumatology Centre, Haywood Hospital, Midlands Partnership NHS Foundation Trust, High Lane , Burslem, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-1028","authenticated-orcid":false,"given":"Christian D","family":"Mallen","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"},{"name":"Haywood Academic Rheumatology Centre, Haywood Hospital, Midlands Partnership NHS Foundation Trust, High Lane , Burslem, Staffordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-5751","authenticated-orcid":false,"given":"Sara","family":"Muller","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-5335","authenticated-orcid":false,"given":"Kelvin P","family":"Jordan","sequence":"additional","affiliation":[{"name":"Primary Care Centre Versus Arthritis, School of Medicine, Keele University , Keele, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"2024060322022787400_kead463-B1","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3899\/jrheum.140976","article-title":"Patient expectations and perceptions of goal-setting strategies for disease management in rheumatoid arthritis","volume":"42","author":"Strand","year":"2015","journal-title":"J Rheumatol"},{"key":"2024060322022787400_kead463-B2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.10515","article-title":"Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority","volume":"47","author":"Heiberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2024060322022787400_kead463-B3","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001994","article-title":"Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy","volume":"8","author":"Taylor","year":"2022","journal-title":"RMD Open"},{"key":"2024060322022787400_kead463-B4","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","article-title":"Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024060322022787400_kead463-B5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13075-022-02903-w","article-title":"Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studies","volume":"24","author":"Ibrahim","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2024060322022787400_kead463-B6","first-page":"797","article-title":"EULAR recommendations for the health professional\u2019s approach to pain management in inflammatory arthritis and osteoarthritis","volume":"77","author":"Geenen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024060322022787400_kead463-B7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3899\/jrheum.120336","article-title":"Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review","volume":"90","author":"Hazlewood","year":"2012","journal-title":"J Rheumatol Suppl"},{"key":"2024060322022787400_kead463-B8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3899\/jrheum.120341","article-title":"The efficacy and safety of opioids in inflammatory arthritis: a Cochrane systematic review","volume":"90","author":"Whittle","year":"2012","journal-title":"J Rheumatol Suppl"},{"key":"2024060322022787400_kead463-B9","author":"National Instiute for Health and Care Excellence (NICE)"},{"key":"2024060322022787400_kead463-B10","author":"National Institue for Health and Care Excellence (NICE)"},{"key":"2024060322022787400_kead463-B11","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.40152","article-title":"Changing trends in opioid use among patients with rheumatoid arthritis in the United States","volume":"69","author":"Curtis","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024060322022787400_kead463-B12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.40789","article-title":"Chronic opioid use in rheumatoid arthritis: prevalence and predictors","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2024060322022787400_kead463-B13","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3899\/jrheum.180972","article-title":"Opioid use in patients with ankylosing spondylitis is common in the United States: outcomes of a retrospective cohort study","volume":"46","author":"Sloan","year":"2019","journal-title":"J Rheumatol"},{"key":"2024060322022787400_kead463-B14","first-page":"2224","article-title":"Opioid prescribing among outpatients with rheumatoid arthritis","volume":"22","author":"Huang","year":"2021","journal-title":"Pain Med Malden Mass"},{"key":"2024060322022787400_kead463-B15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2019.06.003","article-title":"Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis","volume":"49","author":"Black","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2024060322022787400_kead463-B16","doi-asserted-by":"crossref","first-page":"105302","DOI":"10.1016\/j.jbspin.2021.105302","article-title":"Opioid use frequency in early axial spondyloarthritis in Finland - a pharmacoepidemic register study","volume":"89","author":"Muilu","year":"2022","journal-title":"Joint Bone Spine"},{"key":"2024060322022787400_kead463-B17","doi-asserted-by":"crossref","first-page":"3891436","DOI":"10.1155\/2020\/3891436","article-title":"Trends in opioid use in a cohort of patients with rheumatoid arthritis","volume":"2020","author":"Machado-Duque","year":"2020","journal-title":"Pain Res Manag"},{"key":"2024060322022787400_kead463-B18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.semarthrit.2020.07.008","article-title":"Racial and ethnic differences in medication use among beneficiaries of social security disability insurance with rheumatoid arthritis","volume":"50","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2024060322022787400_kead463-B19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.24341","article-title":"Obesity and the risk of incident chronic opioid use in rheumatoid arthritis","volume":"73","author":"Baker","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2024060322022787400_kead463-B20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/pds.4202","article-title":"Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study","volume":"26","author":"Jobski","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024060322022787400_kead463-B21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jaad.2021.07.028","article-title":"Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: a cross-sectional study","volume":"86","author":"Loft","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2024060322022787400_kead463-B22","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/rheumatology\/keaa892","article-title":"Changes in the pharmacological management of rheumatoid arthritis over two decades","volume":"60","author":"Crossfield","year":"2021","journal-title":"Rheumatology (Oxf Engl)"},{"key":"2024060322022787400_kead463-B23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40744-021-00344-6","article-title":"Pain medication and corticosteroid use in ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis in the united states: a retrospective observational study","volume":"8","author":"Hunter","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2024060322022787400_kead463-B24","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1093\/rheumatology\/keab870","article-title":"Analgesic prescribing in patients with inflammatory arthritis in England: an observational study using electronic healthcare record data","volume":"61","author":"Scott","year":"2022","journal-title":"Rheumatology"},{"key":"2024060322022787400_kead463-B25","author":"Clinical Practice Research Datalink"},{"key":"2024060322022787400_kead463-B26","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2024060322022787400_kead463-B27","author":"NHS Digital"},{"key":"2024060322022787400_kead463-B28","author":"NHS Digital"},{"key":"2024060322022787400_kead463-B29","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.lanepe.2022.100519","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data","volume":"23","author":"Scott","year":"2022","journal-title":"Lancet Reg Health - Eur"},{"key":"2024060322022787400_kead463-B30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/j.1532-2149.2012.00189.x","article-title":"The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: an observational database study","volume":"17","author":"Bedson","year":"2013","journal-title":"Eur J Pain Lond Engl"},{"key":"2024060322022787400_kead463-B31","author":"Clinical Practice Research Datalink"},{"key":"2024060322022787400_kead463-B32","author":"Clinical Practice Research Datalink"},{"key":"2024060322022787400_kead463-B33","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/j.pain.0000000000000557","article-title":"Trends in long-term opioid prescribing in primary care patients with musculoskeletal conditions: an observational database study","volume":"157","author":"Bedson","year":"2016","journal-title":"Pain"},{"key":"2024060322022787400_kead463-B34","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/j.pain.0000000000001612","article-title":"The contribution of obesity to prescription opioid use in the United States","volume":"160","author":"Stokes","year":"2019","journal-title":"Pain"},{"key":"2024060322022787400_kead463-B35","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2105\/AJPH.2009.180646","article-title":"Age and gender trends in long-term opioid analgesic use for noncancer pain","volume":"100","author":"Campbell","year":"2010","journal-title":"Am J Public Health"},{"key":"2024060322022787400_kead463-B36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pds.4929","article-title":"Long-term opioid therapy definitions and predictors: a systematic review","volume":"29","author":"Karmali","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024060322022787400_kead463-B37","author":"Public Health England","year":"2019"},{"key":"2024060322022787400_kead463-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"2024060322022787400_kead463-B39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000337","article-title":"Sex differences in prescription opioid use","volume":"30","author":"Serdarevic","year":"2017","journal-title":"Curr Opin Psychiatry"},{"key":"2024060322022787400_kead463-B40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/rheumatology\/keaa244","article-title":"Initial analgesic prescriptions for osteoarthritis in the United Kingdom, 2000-2016","volume":"60","author":"Zeng","year":"2021","journal-title":"Rheumatology (Oxf, Engl)"},{"key":"2024060322022787400_kead463-B41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/postgradmedj-2020-138944","article-title":"Associations between socioeconomic deprivation and pharmaceutical prescribing in primary care in England","volume":"98","author":"Mooney","year":"2022","journal-title":"Postgrad Med J"},{"key":"2024060322022787400_kead463-B42","first-page":"CD010952","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)","volume":"2015","author":"Kroon","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024060322022787400_kead463-B43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024060322022787400_kead463-B44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40744-019-00175-6","article-title":"Changes in opioid utilization following tumor necrosis factor inhibitor initiation in patients with rheumatoid arthritis","volume":"6","author":"Park","year":"2019","journal-title":"Rheumatol Ther"},{"key":"2024060322022787400_kead463-B45","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s12325-017-0596-6","article-title":"Changes in healthcare utilization after etanercept initiation in patients with rheumatoid arthritis: a retrospective claims analysis","volume":"34","author":"Accortt","year":"2017","journal-title":"Adv Ther"},{"key":"2024060322022787400_kead463-B46","author":"National Institute for Health and Care Excellence"},{"key":"2024060322022787400_kead463-B47","author":"National Institute for Health and Care Excellence"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead463\/51971763\/kead463.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/6\/1672\/58064900\/kead463.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/6\/1672\/58064900\/kead463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T23:49:11Z","timestamp":1717458551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/6\/1672\/7303712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9,7]]},"published-print":{"date-parts":[[2024,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead463","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,1]]},"published":{"date-parts":[[2023,9,7]]}}}